Folate-PEG-CKK2-DTPA, a potential carrier for lymph-metastasized tumor targeting

Pharmaceutical Research

Volumn 27, Issue 5, 2010, Pages 933-942

  Gu, Bing ^a   Xie, Cao ^a   Zhu, Jianhua ^a   He, Wei ^b   Lu, Weiyue ^a  

^a FUDAN UNIVERSITY   (China)

^b HUADONG HOSPITAL AFFILIATED TO FUDAN UNIVERSITY   (China)

Author keywords

Fluorescent imaging; Folate PEG CKK2 DTPA; Lymph targeting; Radio active tracing; Tumor targeting

Indexed keywords

DIAGNOSTIC AGENT; FOLATE MACROGOL CYSTEINYLLYSINE 2 LYSINE PENTETIC ACID; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CONTROLLED STUDY; DRUG DISTRIBUTION; EX VIVO STUDY; FLUORESCENCE ANALYSIS; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; ISOTOPE LABELING; LYMPH NODE METASTASIS; MALE; MOUSE; MOUTH CANCER; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNTHESIS;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; FOLIC ACID; HUMANS; ISOTOPE LABELING; KB CELLS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; PENTETIC ACID; POLYETHYLENE GLYCOLS; RABBITS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TECHNETIUM TC 99M PENTETATE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77953284616     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0100-3     Document Type: Article

References (37)

1. Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev. 2001; 50: 3-20.
2. Hanahanand D, Weinberg RA. The hallmarks of cancer, Cell. 2000; 100: 57-70.
3. Oussorenand C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev. 2001; 50: 143-156 (Pubitemid 32727280)
4. Torchilin VP. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev. 2002; 54: 235-252
5. Torabi M, Aquino SL, Harisinghani MG. Current Concepts in Lymph Node Imaging. J Nucl Med. 2004; 45: 1509-1518 (Pubitemid 47618505)
6. Kishimoto H, Kojima T, Watanabe Y, Kagawa S, Fujiwara T, Uno F, et al. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat Med. 2006; 12: 1213-1219
7. Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CA, Brechbiel MW, et al. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging. 2007; 25: 866-871 (Pubitemid 46516742)
8. Moghimiand SM, Bonnemain B. Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. Adv Drug Deliv Rev. 1999; 37: 295-312. (Pubitemid 29164514)
9. Tanis PJ, Boom RPA, Koops HS, Faneyte IF, Peterse JL, Nieweg OE, et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol. 2001; 8: 222-226 (Pubitemid 32294802)
10. Korst RJ, Ailawadi M, Lee JM, Lee S, Yamada R, Mahtabifard A, et al. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene. Hum Gene Ther. 2001; 12: 1639-1649 (Pubitemid 32911734)
11. Konno H, Tadakuma T, Kumai K, Takahashi T, Ishibiki K, Abe O, et al. The antitumor effects of adriamycin entrapped in liposomes on lymph node metastases. Jpn J Surg. 1990; 20: 424-428 (Pubitemid 20308787)
12. Khato J, Priester ER, Sieber SM, Enhanced lymph node uptake of melphalan following liposomal entrapment and effects on lymph node metastasis in rats. Cancer Treat Rep. 1982; 66: 517-527 (Pubitemid 12084945)
13. Kaledin VI, Matienko NA, Nikolin VP, Gruntenko YV, Budker VG. Intralymphatic administration of liposome-encapsulated drugs to mice: possibility for suppression of the growth of tumor metastases in the lymph nodes. J Natl Cancer Inst. 1981; 66: 881-887
14. Cai S, Xie Y, Bagby TR, Cohen MS, Forrest ML. Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J Surg Res. 2008: 147: 247-252
15. Oussoren C, Eling WMC, Crommelin DJA, Storm G, Zuidema J. The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochim. Biophys Acta, Biomembranes. 1998; 1369: 159-172 (Pubitemid 28129268)
16. Sudimackand J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev. 2000; 41: 147-162 (Pubitemid 30122955)
17. Shia J, Klimstra DS, Nitzkorski JR, Low PS, Gonen M, Landmann R, et al. Immunohistochemical expression of folate receptor [alpha] in colorectal carcinoma: patterns and biological significance. Human Pathol. 2008; 39: 498-505. (Pubitemid 351375020)
18. Nabil FS, Xu W, Susan M, Mourad T, Kwangjae C, Shuming N, et al. Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head & Neck. 2009; 31: 475-481
19. Kennedy MD, Jallad KN, Thompson. DH, Ben-Amotz D, Low PS. Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J Biomed Opt. 2003; 8: 636-641
20. Mathias CJ, Wang S, Waters DJ, Turek JJ, Low PS, Green MA. Indium-111-DTPA-Folate as a potential folate receptor-targeted radiopharmaceutical. J Nucl Med. 1998; 39: 1579-1585 (Pubitemid 28459891)
21. Fisher RE, Siegel BA, Edell SL, Oyesiku NM, Morgenstern DE, Messmann RA, et al. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J Nucl Med. jnumed. 107.049478 (2008).
22. Müller C, Forrer F, Schibli R, Krenning EP, de Jong M. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-Radiofolate. J Nucl Med. 2008; 49: 310-317 (Pubitemid 351225671)
23. Moghimiand M, Moein Moghimi S. Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake. J Drug Target. 2008; 16: 586-590
24. Moghimi SM. The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes. Biomaterials. 2006; 27: 136-144
25. Liu S, Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Deliv Rev. 2008; 60: 1347-1370
26. Kaiser RLCE, Bossinger CD, Cook PI. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. 1970; 34: 595-598.
27. Liu M, Xu W, Xu L-J, Zhong G-R, Chen S-L, Lu W-Y. Synthesis and biological evaluation of diethylenetriamine pentaacetic acidpolyethylene glycol-folate: a new folate-derived, (99m)Tc-based radiopharmaceutical. Bioconjug Chem. 2005; 16: 1126-1132
28. Mathias CJ, Hubers D, Low PS, Green MA. Synthesis of [(99m) Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconjug Chem. 2000; 11: 253-257
29. Bettio A, Honer M, Müller C, Bruhlmeier M, Muller U, Schibli R, et al. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptorpositive tumors. J Nucl. Med. 2006; 47: 1153-1160 (Pubitemid 47544910)
30. Muller C, Hohn A, Schubiger PA, Schibli R. Preclinical evaluation of novel organometallic 99mTc-folate and 99mTcpteroate radiotracers for folate receptor-positive tumour targeting. Eur J Nucl Med Mol Imaging. 2006; 33: 1007-1016 (Pubitemid 44215666)
31. Leamon CP, DePrince RB, Hendren RW. Folate-mediated drug delivery: effect of alternative conjugation chemistry. J Drug Target. 1999; 7: 157-169
32. Maisano F, Gozzini L, De Haen C. Coupling of DTPA to proteins: a critical analysis of the cyclic dianhydride method in the case of insulin modification. Bioconjug Chem. 2002; 3: 212-217
33. McLennan DN, Porter CJH, Charman SA. Subcutaneous drug delivery and the role of the lymphatics. Drug Discov Today Technol. 2005; 2: 89-96. (Pubitemid 40946313)
34. Harrell MI, Iritani BM, Ruddell A. Lymph node mapping in the mouse. J Immunol Methods. 2008; 332: 170-174
35. Hawley AE, Davis SS, Ilium L. Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev. 1995; 17: 129-148
36. Illum L, Hunneyball IM, Davis SS. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal-macrophages. Int J Pharm. 1986; 29: 53-65. (Pubitemid 16162496)
37. Birn H, Nielsen S, Christensen EI. Internalization and apical-tobasolateral transport of folate in rat kidney proximal tubule. Am J Physiol Renal Physiol. 1997; 272: F70-8.